|
|
|
Insider
Information: |
Higgins John L |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
2,806,928 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$49,374,432 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
2,806,928 |
|
|
Total
Value |
$49,374,432 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
11
|
Stock
price went up :
|
0
|
5
|
Stock
price went down : |
0
|
6
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-34.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ligand Pharmaceuticals Inc |
LGND |
Director |
2022-12-28 |
417,695 |
2007-02-01 |
0 |
Premium* |
|
Techne Corp |
TECH |
Director |
2024-05-14 |
36,608 |
2013-10-31 |
0 |
Premium* |
|
OmniAb, Inc |
OABI |
Director |
2024-01-30 |
2,352,625 |
2022-11-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
165 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TECH |
Techne Corp |
Director |
|
2020-02-12 |
4 |
S |
$205.23 |
$1,026,133 |
D/D |
(5,000) |
4,021 |
0 |
% |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2020-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
13,559 |
210,289 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2020-02-13 |
4 |
D |
$95.68 |
$479,261 |
D/D |
(5,009) |
196,730 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2020-02-13 |
4 |
OE |
$9.96 |
$479,325 |
D/D |
48,125 |
201,739 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2020-02-15 |
4 |
D |
$97.23 |
$497,429 |
D/D |
(5,116) |
205,173 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2020-07-07 |
4 |
OE |
$56.26 |
$302,098 |
D/D |
4,315 |
204,571 |
0 |
- |
|
TECH |
Techne Corp |
|
|
2020-10-29 |
4 |
A |
$0.00 |
$0 |
D/D |
391 |
4,412 |
0 |
- |
|
TECH |
Techne Corp |
|
|
2020-11-06 |
4 |
S |
$298.98 |
$1,501,744 |
D/D |
(5,000) |
4,412 |
0 |
% |
|
TECH |
Techne Corp |
|
|
2020-11-06 |
4 |
OE |
$70.35 |
$351,750 |
D/D |
5,000 |
9,412 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2020-11-09 |
4 |
D |
$81.77 |
$200,991 |
D/D |
(2,458) |
222,113 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2020-11-09 |
4 |
OE |
$10.05 |
$201,000 |
D/D |
20,000 |
224,571 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2020-12-08 |
4 |
OE |
$10.05 |
$147,303 |
D/D |
14,657 |
236,770 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2020-12-08 |
4 |
D |
$87.52 |
$147,296 |
D/D |
(1,683) |
235,087 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2020-12-31 |
4 |
A |
$84.53 |
$18,851 |
D/D |
223 |
235,310 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2021-01-25 |
4 |
OE |
$14.47 |
$723,500 |
D/D |
50,000 |
285,310 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2021-01-25 |
4 |
AS |
$159.00 |
$7,950,000 |
D/D |
(50,000) |
235,310 |
0 |
% |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2021-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
15,553 |
248,018 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2021-01-25 |
4 |
D |
$156.01 |
$1,160,870 |
D/D |
(7,441) |
243,422 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2021-01-27 |
4 |
AS |
$182.00 |
$7,280,000 |
D/D |
(40,000) |
243,422 |
0 |
% |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2021-01-27 |
4 |
OE |
$14.47 |
$1,236,400 |
D/D |
70,000 |
273,422 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2021-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
12,608 |
286,030 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2021-02-05 |
4 |
D |
$203.03 |
$602,999 |
D/D |
(2,970) |
343,060 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2021-02-05 |
4 |
OE |
$10.05 |
$1,394,017 |
D/D |
114,666 |
346,030 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2021-02-05 |
4 |
AS |
$203.40 |
$11,119,239 |
D/D |
(54,666) |
286,030 |
0 |
% |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2021-02-15 |
4 |
D |
$172.46 |
$898,862 |
D/D |
(5,212) |
337,848 |
0 |
- |
|
165 Records found
|
|
Page 5 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|